ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

Scientific Session 5: Mechanisms of Resistance and New Targets
15:26

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

A Genome-scale CRISPR Knock-out Screen in Chronic Myeloid Leukemia Identifies Common Drug Resistance Mechanisms Implicating Apoptotic and Transcriptional Machineries

FEATURING Matthieu Lewis
  • 11 views
  • January 2, 2019
13:48

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Single-molecule Sequencing Reveals Patterns of Pre-existing Drug Resistance that Suggest Treatment Strategies in Philadelphia-positive Leukemias

FEATURING Justin Pritchard
  • 8 views
  • December 3, 2018
12:49

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Modulation of p53 with the MDM2 Antagonist Idasanutlin, in Combination with Nilotinib Treatment, Targets Primitive CML Cells in Vitro and in Vivo

FEATURING David Vetrie
  • 13 views
  • January 2, 2019